MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Molecular Pharmacology Fast Forward
First published on October 27, 2004; DOI: 10.1124/mol.104.006973

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.006973v1
67/2/365    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Karin Pleban
Stephan Kopp
Gerhard F Ecker
Peter Chiba
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pleban, K.
Right arrow Articles by Chiba, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pleban, K.
Right arrow Articles by Chiba, P.


Received for publication September 7, 2004.
Revised October 26, 2004.
Accepted for publication October 27, 2004.

P-glycoprotein substrate binding domains are located at the transmembrane domain : transmembrane domain interfaces - A combined photoaffinity labeling - protein homology modeling approach

Karin Pleban 1, Stephan Kopp 2, Edina Csaszar 3, Michael Peer 2, Thomas Hrebicek 4, Andreas Rizzi 4, Gerhard F Ecker 1, Peter Chiba 2*

1 Department of Pharmaceutical Chemistry, Univ. Vienna 2 Institute of Medical Chemistry, Medical Univ. of Vienna 3 The Mass Spectrometry Unit, Univ. Vienna 4 Institute of Analytical Chemistry, Univ. Vienna

* Address correspondence to: E-mail: peter.chiba{at}meduniwien.ac.at

Abstract

P-glycoprotein (P-gp) is an energy dependent multidrug efflux pump conferring resistance to cancer-chemotherapy. Characterization of the mechanism of drug transport at a molecular level represents an important prerequisite for the design of pump inhibitors, which resensitize cancer cells to standard chemotherapy. In addition, P-glycoprotein plays an important role for early ADMET (absorption, distribution, metabolism, excretion and toxicity) profiling in drug development. A set of propafenone-type substrate photoaffinity ligands has been used in this study in conjunction with MALDI-TOF mass-spectrometry to define the substrate-binding-domain(s) of P-gp in more detail. Highest labeling was observed in transmembrane segments 3, 5, 8 and 11. A homology model for P-gp was generated based on the dimeric crystal structure of Vibrio cholerae MsbA (Vc-MsbA), an essential lipid transporter. Subsequently, the labeling pattern was projected onto the 3D atomic detail model of P-gp to allow a visualization of the binding domain(s). Labeling is predicted by the model to occur at the two TMD:TMD interfaces formed between the amino- and carboxy terminal half of P-gp. These interfaces are formed by TM segments 3 and 11 on one hand and TM segments 5 and 8 on the other hand. Available data on LmrA and AcrB, two bacterial multidrug efflux pumps, suggest that binding at domain interfaces may be a general feature of polyspecific drug efflux pumps.


Key words: MDR/p-Glycoprotein, Thermodynamic and kinetic processes and modeling, Mass Spectroscopy, Resistance


This article has been cited by other articles:


Home page
 Microbiol. Mol. Biol. Rev.Home page
A. L. Davidson, E. Dassa, C. Orelle, and J. Chen
Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems
Microbiol. Mol. Biol. Rev., June 1, 2008; 72(2): 317 - 364.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. W. Loo, M. C. Bartlett, and D. M. Clarke
Suppressor Mutations in the Transmembrane Segments of P-glycoprotein Promote Maturation of Processing Mutants and Disrupt a Subset of Drug-binding Sites
J. Biol. Chem., November 2, 2007; 282(44): 32043 - 32052.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. Wu, C. J. Oleschuk, Q. Mao, B. O. Keller, R. G. Deeley, and S. P. C. Cole
Analysis of Human Multidrug Resistance Protein 1 (ABCC1) by Matrix-Assisted Laser Desorption Ionization/Time of Flight Mass Spectrometry: Toward Identification of Leukotriene C4 Binding Sites
Mol. Pharmacol., November 1, 2005; 68(5): 1455 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
B. Woebking, G. Reuter, R. A. Shilling, S. Velamakanni, S. Shahi, H. Venter, L. Balakrishnan, and H. W. van Veen
Drug-Lipid A Interactions on the Escherichia coli ABC Transporter MsbA
J. Bacteriol., September 15, 2005; 187(18): 6363 - 6369.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics